Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 213

The DOI matches its Crossref record.

Colchicine Treatment for the Prevention of Bare-Metal Stent Restenosis in Diabetic Patients

Open access
Deftereos, Spyridon, Giannopoulos, Georgios, Raisakis, Konstantinos, Kossyvakis, Charalambos, Kaoukis, Andreas, Panagopoulou, Vasiliki, Driva, Metaxia, Hahalis, George, Pyrgakis, Vlasios, Alexopoulos, Dimitrios, Manolis, Antonis S., Stefanadis, Christodoulos, Cleman, Michael W. · 2013 · Journal of the American College of Cardiology

Abstract

OBJECTIVES This study sought to test the hypothesis that colchicine treatment after percutaneous coronary intervention (PCI) can lead to a decrease in in-stent restenosis (ISR). BACKGROUND ISR rates are particularly high in certain patient subsets, including diabetic patients, especially when a bare-metal stent (BMS) is used. Pharmacological interventions to decrease ISR could be of clinical relevance. METHODS Diabetic patients with contraindication to a drug-eluting stent, undergoing PCI with a BMS, were randomized to receive colchicine 0.5 mg twice daily or placebo for 6 months. Restenosis and neointima formation were studied with angiography and intravascular ultrasound 6 months after the index PCI. RESULTS A total of 196 patients (63.6 ± 7.0 years of age, 128 male) were available for analysis. The angiographic ISR rate was 16% in the colchicine group and 33% in the control group (p = 0.007; odds ratio: 0.38, 95% confidence interval: 0.18 to 0.79). The number needed to treat to avoid 1 case of angiographic ISR was 6 (95% confidence interval: 3.4 to 18.7). The results were similar for IVUS-defined ISR (odds ratio: 0.42; 95% confidence interval: 0.22 to 0.81; number needed to treat = 5). Lumen area loss was 1.6 mm(2) (interquartile range: 1.0 to 2.9 mm(2)) in colchicine-treated patients and 2.9 mm(2) (interquartile range: 1.4 to 4.8 mm(2)) in the control group (p = 0.002). Treatment-related adverse events were largely limited to gastrointestinal symptoms. CONCLUSIONS Colchicine is associated with less neointimal hyperplasia and a decreased ISR rate when administered to diabetic patients after PCI with a BMS. This observation may prove useful in patients undergoing PCI in whom implantation of a drug-eluting stent is contraindicated or undesirable.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2013.01.055

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 213

Metadata

Authors
Deftereos, S., Giannopoulos, G., Raisakis, K., Kossyvakis, C., Kaoukis, A., Panagopoulou, V., Driva, M., Hahalis, G., Pyrgakis, V., Alexopoulos, D., Manolis, A. S., Stefanadis, C., & Cleman, M. W.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2013-04
Volume
61
Issue
16
Pages
1679-1685
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2000793756
Cited by
213
References
0
FWCI
13.47
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Colchicine Treatment for the Prevention of Bare-Metal Stent Restenosis in Diabetic Patients. https://app.cochat.ai/papers/10.1016/j.jacc.2013.01.055
The paper
Deftereos, S., Giannopoulos, G., Raisakis, K., Kossyvakis, C., Kaoukis, A., Panagopoulou, V., Driva, M., Hahalis, G., Pyrgakis, V., Alexopoulos, D., Manolis, A. S., Stefanadis, C., & Cleman, M. W. (2013). Colchicine Treatment for the Prevention of Bare-Metal Stent Restenosis in Diabetic Patients. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2013.01.055

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.